Find your path to Troy
481 people in our graph share verified history with Troy — schools, employers, funds. One of them is your warm intro.
Greg RudinunlockedTroy: together at Creative Destruction Lab (2025–2026)
Troy: together at Ochre Bio
×2Troy: together at Creative Destruction Lab
×6Troy: together at University of Leeds
About
Troy Dale is a pharmaceutical executive who has held CEO and board positions while serving as an angel investor with Springboard Health Angels. He has experience leading teams across organizational scales and executing strategy from conception through implementation. His background includes work in strategic planning and problem-solving across complex business environments.
Experience
- Springboard Health AngelsAngel Investorcurrent2023 — presentBerlin, Germany
- Creative Destruction LabBusiness mentorcurrent2022 — presentBerlin, Germany
- Meddenovo Drug DesignStrategic Advisorcurrent2025 — presentLyon, Auvergne-Rhône-Alpes, France
- Cellbricks TherapeuticsChairperson of the Boardcurrent2024 — presentBerlin, Germany
- SyntropicInvestor and Strategic Advisorcurrent2024 — presentVienna, Austria
- Ochre BioMember of SABcurrent2022 — presentLondon, England, United Kingdom
- Noa TherapeuticsFractional CBO2024 — 2026
- Newton Venture ProgramNewton Fellow2024 — 2025London Area, United Kingdom
- NovartisHead Commercial - Strategic Partnerships Unit (Vice President)2014 — 2024Basel Area, Switzerland
- NovartisGlobal Head: Market Access - Neuroscience (ad interim in addiotion to other roles)2013 — 2014Basel Area, Switzerland
- NovartisGlobal Head: Market Access - Critical Care2011 — 2014Basel
- NovartisGlobal Head:Market Access Respiratory2011Basel Area, Switzerland
- NovartisGlobal Head Marketing and Sales: Established Medicines2007 — 2011Basel Area, Switzerland
- sanofi-aventisChief Marketing Officer2005 — 2007Shanghai, China
- sanofi-aventisDivisional Sales Manager2004 — 2005New York, United States
- sanofi-aventisMarketing Director Venous Thrombosis1999 — 2004Paris, Île-de-France, France
- sanofi-aventisvarious marketing1992 — 1999
Skills & more
Financial AnalysisGo-to-Market StrategyPresentationsInternational Marketing1Business Analysis1Corporate GovernanceBusiness DevelopmentCross-functional Team LeadershipDue DiligenceBusiness StrategySales & MarketingStrategic Marketing
+12 more
Market AnalysisBrand AlignmentClinical TrialsMarket AccessRespirationBiologicsPricingHospital SalesTeam ManagementLeadershipStrategic PlanningStrategic ThinkingLanguages Chinese - conversational · English · French · German
From Troy's professional profile.
Colleagues at ACT Venture Partners
Aleksandar Terziyski
Venture Partner at ACT Venture Partners
Alper Alsan
Executive in Residence at ACT Venture Partners
Berrak Selek
Executive in Residence at ACT Venture Partners
Erhan Ercan
Executive in Residence at ACT Venture Partners
Erhan Kılıçözlü
Managing Partner at ACT Venture Partners
Evren Ucok
Strategy Advisor at ACT Venture Partners
Gökhan Güner
Managing Partner at ACT Venture Partners
Gürcan Ozan
Partner at ACT Venture Partners
Frequently asked questions
- Who is Troy Dale?
- Troy Dale is a pharmaceutical executive who has held CEO and board positions while serving as an angel investor with Springboard Health Angels. He has experience leading teams across organizational scales and executing strategy from conception through implementation. His background includes work in strategic planning and problem-solving across complex business environments.
- Where does Troy Dale work?
- Troy Dale is Executive in Residence at ACT Venture Partners.
- Where did Troy Dale go to school?
- Troy Dale studied at Harvard Business School (Executive Development, Business Finance); Guildhall University (Professional DIploma, Marketing); University of Leeds (BSc (Honours), Pharmacology).
Same school
Also attended Harvard Business School2,000
Brad GerstnerFounder & CEO of Altimeter CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesJim BreyerFounder & CEO of Breyer CapitalTim DraperFounder of Draper AssociatesMike Maples JrCo-founding Partner at FloodgateMamoon HamidPartner at Kleiner Perkins
+ 1,994 more
Also attended University of Leeds189
Joseph StolermanInvestor at Index VenturesLaura CliffordTalent Director at NorthzoneJason MorrisVice President, Investor Relations at Sapphire VenturesIan MilbournGeneral Partner & COO at Notion CapitalJohn MesrieOperating Partner at Inreach VenturesPhil TomkinsonFinance & Portfolio Associate at Giant Ventures Global Llp
+ 183 more
Shared employers
Also worked at Meddenovo Drug Design1
Also worked at Cellbricks Therapeutics2
Also worked at Ochre Bio6
Also worked at Newton Venture Program54
Christopher SisserianHead of Platform at Manta Ray VenturesFrancois PrinslooInvestor at MedicxiKenneth K ThomasPrincipal at Backfuture Ventures, LlcBarbaros OzbugutuExperts | Leadership Management at 212Ipek CeliksozExperts | Venture Partner at 212Ijaz KhanAssociate at Blackfinch Ventures
+ 48 more